Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation

BACKGROUND: Dual antiplatelet treatment (DAPLT) for at least 12 months is recommended after drug eluting stent (DES) implantation, but concerns regarding the extended use of this treatment persist due to increased risk of bleeding. In this study are assessed the incidence, correlates, and clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Voudris, Vassilis, Karyofyllis, Panagiotis, Doulaptsis, Constantinos, Moukas, Ioannis, Thomopoulou, Sofia, Cokkinos, Denis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497144/
https://www.ncbi.nlm.nih.gov/pubmed/28785613
http://dx.doi.org/10.1016/j.ijcha.2014.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497144/
https://www.ncbi.nlm.nih.gov/pubmed/28785613
http://dx.doi.org/10.1016/j.ijcha.2014.10.007

Ejemplares similares